Organ Transplantation

Organ transplantation is a surgical treatment in which an organ from a donor is placed into a recipient to take over the work of an organ that has failed. It is considered when an organ is so damaged that it can no longer do its job and cannot be restored by medication or other treatment. The donor may be a living person, who can safely give one of two kidneys or part of the liver, or a deceased donor after brain death, whose organs are donated according to law and consent. Because the body's immune system would otherwise treat the new organ as foreign, donor and recipient are matched carefully, and medication is used afterwards to help the body accept the graft. Transplantation is always the work of a multidisciplinary team rather than a single surgeon, and the whole programme around the operation shapes the result.

Transplantation answers the needs of patients with advanced or end stage organ failure. Kidney transplantation is offered for end stage kidney disease, often in people who depend on dialysis, from causes such as long standing high blood pressure, diabetes, chronic inflammation or inherited kidney disease. Liver transplantation is used for end stage liver disease and severe liver failure, from cirrhosis, chronic viral or metabolic liver disease, certain tumours confined to the liver and some inherited conditions, and in children for problems present from birth. The field includes living-donor and deceased-donor pathways, pediatric transplantation for children, and the supporting sub-specialties of transplant hepatology and nephrology, which manage the patient before and after surgery, and transplant immunology and tissue typing, which match donor and recipient and guide anti-rejection care.

The central treatments are the transplant operations themselves and the careful pathway around them. In a living-donor kidney transplant, a healthy donor gives one kidney, which is possible because a person can live well with the remaining one. In a living-donor liver transplant, the donor gives part of the liver, which can regrow in both donor and recipient because the liver is able to regenerate. In a deceased-donor transplant, the organ comes from a donor after brain death. Before any of this, both donor and recipient undergo detailed evaluation to confirm that donating is safe and that the organ is a good match. After the operation, the most important ongoing treatment is immunosuppressive medication, which lowers the risk that the body rejects the new organ, balanced carefully against the risk of infection. Lifelong specialist follow-up protects the new organ for years to come.

Transplantation depends on precise evaluation as much as on surgery. The recipient is studied in depth to confirm that a transplant is needed and safe, with blood tests of organ and overall function, imaging such as ultrasound, CT and MRI to map the organ and its blood vessels, and assessment of the heart, lungs and infection risk before surgery. A potential living donor undergoes an equally thorough evaluation to confirm that donating is safe for them. Tissue typing and crossmatch testing compare the immune profiles of donor and recipient to find a suitable match and predict the risk of rejection. In the operating room, transplantation relies on advanced surgical and microsurgical technique to connect fine blood vessels and ducts, supported by intensive care afterwards. Continued blood tests and imaging then monitor the new organ and guide the balance of medication over the long term.

For people who travel, the pathway usually begins with a remote review of medical records and recent test results, so the team can confirm whether a transplant is appropriate and what evaluation is still needed. When a living donor is involved, that donor is assessed with the same care as the patient. After arrival, detailed testing of recipient and donor is completed before surgery is scheduled, and length of stay is significant: the recipient typically remains in hospital for about one to several weeks and then nearby for further recovery and monitoring, while a living donor usually has a shorter stay. Because the new organ and the medication that protects it need close attention, the team gives a clear plan for follow-up, and arranges remote review and coordination with doctors near the patient's home. Interpreter and international patient support assist with consent, communication and logistics throughout.